Market Dynamics:
The global kidney cancer drugs market is witnessing high growth owing to rising incidences of kidney cancer across the globe. According to statistics provided by American Cancer Society, in 2022, around 79,000 new cases of kidney cancer will be diagnosed in America. Additionally, global lifestyle changes such as smoking, obesity and increased intake of processed foods are major risk factors fueling the cases of kidney cancer. Furthermore, growing awareness regarding early diagnosis and effective treatment is another factor propelling the market growth. However, high cost associated with targeted therapies for kidney cancer treatment remains a challenge.

Key Takeaways
The Global Kidney Cancer Drugs Market Size is expected to witness high growth, exhibiting CAGR of 6.4% over the forecast period, due to increasing incidence of renal cell carcinoma (RCC). According to statistics, more than 431,000 new cases of kidney cancer are diagnosed globally each year.

For More Insights, Read: https://newsinsights123.blogspot.com/2023/12/immunotherapy-is-fastest-growing.html